Chemicals · Chemicals: Specialty · NSE: GANESHBE · data 2026-11-01
Ganesh Benzoplast Limited
In plain words
Price: 38.4% below its 52-week high of ₹143.
Delivery: 32.3% of traded shares were kept for delivery over the last 10 sessions, against 51.2% over the last 60.
Latest results: a net profit of ₹17 cr for the quarter ended Jun 2026 (-8.5% on the same quarter a year earlier).
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹433 cr |
| Net profit (last 12 months) | ₹73 cr |
| Sales growth, 3 years (yearly) | -0.7% |
| Profit growth, 3 years (yearly) | 9.7% |
At a glance
Promoters 39.0% (unchanged in a year), pledged 0.0%, institutions 2.1%.
P/E 8.7, dividend yield 0.0%. Price relative to earnings and book value (low is cheaper, not better).
ROE 12.6%, ROCE 11.6%, operating margin 15.5%: how much profit it earns on the money it uses.
Debt/equity 0.12, Profit growth 9.7% and sales growth -0.7% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Latest results in brief (Q1 FY27)
GANESHBE Q1 FY27 results (consolidated figures, as filed on NSE).
Revenue was ₹117.5 crore, up 22.9% YoY and up 5.4% QoQ.
Net profit was ₹16.56 crore, down 8.5% YoY and up 8.3% QoQ.
Operating margin was 23% (30.4% a year ago).
EPS was ₹2.44, down 3.2% YoY and up 15.1% QoQ.
GANESHBE के Q1 FY27 नतीजे (कंसोलिडेटेड आंकड़े, NSE पर दाखिल)।
राजस्व: ₹117.5 करोड़; पिछले साल की तुलना में 22.9% की बढ़त, पिछली तिमाही की तुलना में 5.4% की बढ़त।
शुद्ध मुनाफ़ा: ₹16.56 करोड़; पिछले साल की तुलना में 8.5% की गिरावट, पिछली तिमाही की तुलना में 8.3% की बढ़त।
ऑपरेटिंग मार्जिन: 23% (एक साल पहले 30.4%)।
EPS: ₹2.44; पिछले साल की तुलना में 3.2% की गिरावट, पिछली तिमाही की तुलना में 15.1% की बढ़त।
GANESHBEના Q1 FY27 પરિણામો (કન્સોલિડેટેડ આંકડા, NSE પર ફાઇલ કરેલા).
આવક (રેવન્યુ): ₹117.5 કરોડ; ગયા વર્ષની સરખામણીએ 22.9% વધારો, ગયા ક્વાર્ટરની સરખામણીએ 5.4% વધારો.
ચોખ્ખો નફો: ₹16.56 કરોડ; ગયા વર્ષની સરખામણીએ 8.5% ઘટાડો, ગયા ક્વાર્ટરની સરખામણીએ 8.3% વધારો.
ઓપરેટિંગ માર્જિન: 23% (એક વર્ષ પહેલાં 30.4%).
EPS: ₹2.44; ગયા વર્ષની સરખામણીએ 3.2% ઘટાડો, ગયા ક્વાર્ટરની સરખામણીએ 15.1% વધારો.
Written from the filed numbers. Not a recommendation.
Smart-money activity
31/100 · Neutral over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Too few delivery days to compare delivery % (0 of 10); shares delivered not comparable (0 of 12); 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 20/20: Net +₹9.94 cr bought in bulk/block deals over 90 days (2.76x a usual day's traded value); 2 net buying days, 0 net selling days.
- Insider / SAST buys 6/15: 0 insider buy days (promoter group among them) and 1 SAST acquisition day in 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Results ● Deal ● Insider
- 14 Oct 26Results Q4 FY26 results: turned to profit vs a year ago -6.7% next session
- 7 Oct 26Deal Bulk deal: YELLOWSTONE INVESTMENTS bought ₹4.89 cr -0.3% next session
- 6 Oct 26Deal Bulk deal: APURVA MAHESH SHAH bought ₹5.05 cr -0.3% next session
- 1 Sept 26Insider SAST disclosure: Ravi Pilani acquired 28,56,810 shares +6.1% next session
- 11 Aug 26Results Q1 FY27 results: profit −8.5% YoY -6.7% next session
- 13 Feb 26Results Q3 FY26 results: profit −6.6% YoY -5.4% next session
- 13 Nov 25Results Q2 FY26 results: profit +45.0% YoY -2.3% next session
- 11 Aug 25Results Q1 FY26 results: profit +10.6% YoY +11.4% next session
- 15 May 25Results Q4 FY25 results: turned to loss vs a year ago +7.2% next session
- 12 Feb 25Results Q3 FY25 results: profit +7.5% YoY -0.6% next session
- 15 Nov 24Results Q2 FY25 results: profit +4.4% YoY -4.3% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Quarterly results (consolidated)
| Quarter | Revenue | Net profit | Profit YoY | Op. margin | EPS ₹ |
|---|---|---|---|---|---|
| Jun 2026 | ₹118 cr | ₹17 cr | -8.5% | 23.0% | 2.44 |
| Mar 2026 | ₹111 cr | ₹15 cr | — | 18.4% | 2.12 |
| Dec 2025 | ₹105 cr | ₹16 cr | -6.6% | 20.8% | 2.24 |
| Sept 2025 | ₹99 cr | ₹24 cr | +45.0% | 22.2% | 3.3 |
Shareholding trend
| Holder | Sept 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
|---|---|---|---|---|
| Promoters | 39.02% | 39.02% | 39.02% | 39.02% |
| Foreign institutions (FII) | 0.53% | 1.13% | 0.73% | 3.45% |
| Domestic institutions (DII) | 1.57% | 0.98% | 0.76% | 0.76% |
| Mutual funds | — | — | — | — |
| Retail investors | 31.49% | 32.26% | 31.95% | 31.75% |
| Number of shareholders | 49,745 | 51,013 | 51,145 | 52,315 |
Common questions
What was Ganesh Benzoplast Limited's latest quarterly profit?
Ganesh Benzoplast Limited reported a net profit of ₹17 cr for the quarter ended Jun 2026 (-8.5% on the same quarter a year earlier), on revenue of ₹118 cr.
How much do promoters hold in Ganesh Benzoplast Limited?
Promoters held 39.02% of Ganesh Benzoplast Limited at the end of Sept 2026, with 0.00% of promoter shares pledged.
Is Ganesh Benzoplast Limited debt-free?
Its latest reported debt-to-equity ratio is 0.12.
What is Ganesh Benzoplast Limited's P/E ratio?
About 8.7, based on the last 12 months' earnings and a price of ₹88.07 (data 2026-11-01).
What is the 52-week high and low of Ganesh Benzoplast Limited?
The 52-week high is ₹143 and the 52-week low is ₹68.4.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Ganesh Benzoplast Limited | ₹88.07 | ₹634 cr | 8.7 | — | 12.6% | 11.6% | 0.12 | +2.0% |
| Transpek Industry Limited | ₹1,221.1 | ₹690 cr | 17.5 | — | 6% | 6.2% | 0.1 | +7.5% |
| Sadhana Nitro Chem Limited | ₹2.25 | ₹682 cr | — | 1.5 | -23.5% | -13.9% | 0.25 | +14.6% |
| Chemcon Speciality Chemicals Ltd | ₹181.84 | ₹673 cr | 22.2 | 1.4 | 4.8% | 3.9% | 0.11 | -28.6% |
| Amal Ltd. | ₹532.65 | ₹660 cr | 22.1 | 4.7 | 20.4% | 23.5% | 0 | -30.1% |
| Kothari Petrochemicals Ltd. | ₹109.06 | ₹642 cr | 8.9 | — | 21.4% | 24.4% | 0.01 | -24.7% |
Compare GANESHBE with TRANSPEK in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open GANESHBE in NSE Scanner →